Abstract

Women outnumber men in US medical school enrollment, but they represent less than 40% of academic oncology faculty. To identify the key factors associated with female oncologists' decision to pursue academic or nonacademic oncology practice and to characterize their perceptions about their current career. This cross-sectional survey study was distributed through email and social media to female physicians in academic and nonacademic oncology practice in the United States. The survey was open for 3 months, from August 1 to October 31, 2020. No single primary study outcome was established because of the cross-sectional nature of the survey. Data were collected anonymously and analyzed using t tests for continuous variables and χ2 tests for categorical variables. Among the 667 female respondents, 422 (63.2%) identified as academic oncologists and 245 (36.8%) identified as nonacademic oncologists. Approximately 25% of respondents reported that their spouse or partner (156 [23.5%]) and/or family (176 [26.4%]) extremely or moderately affected their decision to pursue academic practice. Academic oncologists perceived the biggest sacrifice of pursuing academics to be time with loved ones (181 [42.9%]). Nonacademic oncologists perceived the biggest sacrifice of pursuing academics to be pressure for academic promotion (102 [41.6%]). Respondents had different perceptions of how their gender affected their ability to obtain a chosen job, with 116 academic oncologists (27.6%) and 101 nonacademic oncologists (41.2%) reporting a positive or somewhat positive impact (P = .001). More than half of the women surveyed (54.6% academic oncologists [230]; 50.6% nonacademic oncologists [123]; P = .61) believed they were less likely to be promoted compared with male colleagues. Academic and nonacademic oncologists reported rarely or never having a sense of belonging in their work environment (33 [7.9%] and 5 [2.0%]; P < .001). Most respondents reported that they would choose the same career path again (301 academic oncologists [71.3%]; 168 nonacademic oncologists [68.6%]); however, 92 academic oncologists (21.9%) reported they were likely to pursue a career outside of academic oncology in the next 5 years. This survey study found that a spouse or partner and/or family were factors in the career choice of both academic and nonacademic oncologists and that female gender was largely perceived to adversely affect job promotion. Given that more than 20% of female academic oncologists were considering leaving academia, gender inequality is at high risk of continuing if the culture is not addressed.

Highlights

  • Underrepresentation of women in academic oncology is a growing concern

  • Most respondents reported that they would choose the same career path again (301 academic oncologists [71.3%]; 168 nonacademic oncologists [68.6%]); 92 academic oncologists (21.9%) reported they were likely to pursue a career outside of academic oncology in the 5 years. This survey study found that a spouse or partner and/or family were factors in the career choice of both academic and nonacademic oncologists and that female gender was largely perceived to adversely affect job promotion

  • Given that more than 20% of female academic oncologists were considering leaving academia, gender inequality is at high risk of continuing if the culture is not addressed

Read more

Summary

Introduction

Underrepresentation of women in academic oncology is a growing concern. Enrollment of women in US medical schools has surpassed that of men, and 45.0% of hematology/oncology fellows, 30.3% of radiation oncology residents, and 70.5% of pediatric hematology/oncology fellows are women. women represent only 35.9% of academic oncology faculty, including 37.1% in hematology/oncology, 30.7% in radiation oncology, 38.8% in surgical oncology, and approximately 50% in pediatric hematology/oncology. Women are underrepresented among the leadership in oncology specialties, occupying 31.4% of the chair positions in medical oncology, 17.4% in radiation oncology, and 11.1% in surgical oncology. Of the most recent leadership roles in professional oncology associations, 3 of the 25 presidents of the American Society for Radiation Oncology, 7 of the 25 presidents of the American Society of Clinical Oncology, 4 of the 25 presidents of the Society of Surgical Oncology, 4 of the 17 presidents of the American Society of Pediatric Hematology/Oncology, and 0 of the 5 directors of the National Cancer Institute were women. Data suggest that, women may be more likely to pursue careers in academic medicine and may have similar research productivity compared with men, they leave academia at a higher rate and are less likely to be promoted or appointed to leadership roles.. Women represent only 35.9% of academic oncology faculty, including 37.1% in hematology/oncology, 30.7% in radiation oncology, 38.8% in surgical oncology, and approximately 50% in pediatric hematology/oncology.. Women are underrepresented among the leadership in oncology specialties, occupying 31.4% of the chair positions in medical oncology, 17.4% in radiation oncology, and 11.1% in surgical oncology.. Of the most recent leadership roles in professional oncology associations, 3 of the 25 presidents of the American Society for Radiation Oncology, 7 of the 25 presidents of the American Society of Clinical Oncology, 4 of the 25 presidents of the Society of Surgical Oncology, 4 of the 17 presidents of the American Society of Pediatric Hematology/Oncology, and 0 of the 5 directors of the National Cancer Institute were women..

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.